Coaching program to help breast cancer survivors return to work
Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work
This study is testing a coaching program to help breast cancer survivors successfully return to work after treatment and see if it improves their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 25 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Institut du Cancer de Montpellier - Val d'Aurelle Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT05056350 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility of a coaching program designed to support breast cancer patients in their return to work after completing adjuvant treatment. Participants will undergo an individual interview to assess their needs, followed by seven coaching workshops spaced over several weeks. The program aims to improve quality of life and reduce psychological distress, with assessments conducted before, one month after, and six months after the workshops. The study also seeks to measure recruitment rates and participant satisfaction with the program.
Who should consider this trial
Good fit: Ideal candidates are adult women aged 18 and older who have completed adjuvant treatment for non-metastatic breast cancer and are seeking to return to work.
Not a fit: Patients with metastatic breast cancer or those who have not completed their adjuvant treatment may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly enhance the ability of breast cancer survivors to reintegrate into the workforce, improving their quality of life.
How similar studies have performed: While similar coaching programs have shown promise in supporting cancer survivors, this specific approach is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Patients cared at the Montpellier Cancer Institute (ICM) for non-metastatic breast cancer who have received adjuvant treatment (radiotherapy and/or chemotherapy) * Patient who has completed adjuvant treatment, except for hormonotherapy * Patient practicing a profession at the time of diagnosis, looking for a job or in professional retraining at the time of diagnosis * Patient expressing spontaneously or on request of the oncologist physical or psychological difficulties in the professional field * Patient wishing to be accompanied for an adapted return to her current job or for a return to a new more adapted job * Patient who signed the informed consent after informed information by her clinician Exclusion Criteria: * Metastatic breast cancer or any other cancer within the last 5 years * Patient who haven't completed herr adjuvant treatment (chemotherapy and/or radiotherapy) * Psychological condition requiring therapeutic support (objectified by the Mini International Neuropsychiatric Interview test (MINI) by identifying a Diagnostic and Statistical Manual (DSM)-IV Axis I psychiatric disorder (American Psychiatric Association, 1994) Sheehan et al., 1998) with the patient's refusal of adequate psychiatric treatment (medicated or not) at the time of inclusion in the study * Severely impaired global cognitive functioning (objectified by an adjusted score of less than 20 on the Montreal Cognitive Assessment (MoCA) test) * Physical inability to answer questionnaires
Where this trial is running
Montpellier
- Institut du Cancer de Montpellier — Montpellier, France (Recruiting)
Study contacts
- Study coordinator: Jean-Pierre Bleuse
- Email: jean-pierre.bleuse@icm.unicancer.fr
- Phone: 04 67 61 31 02
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.